AGTC
Income statement / Annual
Last year (2022), Applied Genetic Technologies Corporation's total revenue was $325.00 K,
a decrease of 35.00% from the previous year.
In 2022, Applied Genetic Technologies Corporation's net income was -$71.42 M.
See Applied Genetic Technologies Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
06/30/2014 |
06/30/2013 |
| Operating Revenue |
$325.00 K |
$500.00 K |
$2.45 M |
$41.69 M |
$24.19 M |
$39.47 M |
$47.36 M |
$2.35 M |
$1.13 M |
$942.00 K |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$325.00 K
|
$500.00 K
|
$2.45 M
|
$41.69 M
|
$24.19 M
|
$39.47 M
|
$47.36 M
|
$2.35 M
|
$1.13 M
|
$942.00 K
|
| Gross Profit Ratio |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$49.52 M
|
$44.40 M
|
$35.78 M
|
$33.18 M
|
$32.18 M
|
$26.22 M
|
$38.86 M
|
$16.53 M
|
$8.50 M
|
$3.13 M
|
| General & Administrative Expenses |
$16.99 M
|
$14.55 M
|
$13.62 M
|
$12.86 M
|
$14.39 M
|
$11.35 M
|
$10.59 M
|
$10.36 M
|
$5.18 M
|
$1.40 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$16.99 M
|
$14.55 M
|
$13.62 M
|
$12.86 M
|
$14.39 M
|
$11.35 M
|
$10.59 M
|
$10.36 M
|
$5.18 M
|
$1.40 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$66.50 M
|
$58.95 M
|
$49.40 M
|
$46.04 M
|
$46.57 M
|
$37.57 M
|
$49.45 M
|
$26.89 M
|
$13.69 M
|
$4.54 M
|
| Cost And Expenses |
$66.50 M
|
$58.95 M
|
$49.40 M
|
$46.04 M
|
$46.57 M
|
$37.57 M
|
$49.45 M
|
$26.89 M
|
$13.69 M
|
$4.54 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$42.00 K
|
$0.00
|
| Interest Expense |
$2.67 M
|
$1.51 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$191.00 K
|
| Depreciation & Amortization |
$1.51 M
|
$1.46 M
|
$1.34 M
|
$1.27 M
|
$1.18 M
|
$912.00 K
|
$567.00 K
|
$376.00 K
|
$334.00 K
|
$285.00 K
|
| EBITDA |
-$64.76 M |
-$56.97 M |
-$46.94 M |
-$4.35 M |
-$20.05 M |
$3.72 M |
-$814.00 K |
-$24.53 M |
-$12.56 M |
-$4.51 M |
| EBITDA Ratio |
-199.25
|
-113.94
|
-19.14
|
-0.1
|
-0.83
|
0.09
|
-0.02
|
-10.42
|
-11.12
|
-4.79
|
| Operating Income Ratio |
-203.9
|
-116.9
|
-19.14
|
-0.1
|
-0.93
|
0.05
|
-0.04
|
-10.42
|
-11.12
|
-3.82
|
| Total Other Income/Expenses Net |
-$2.58 M
|
-$1.49 M
|
$1.13 M
|
$2.46 M
|
$1.18 M
|
$905.00 K
|
$708.00 K
|
$214.00 K
|
-$3.35 M
|
-$1.40 M
|
| Income Before Tax |
-$68.75 M
|
-$59.94 M
|
-$45.81 M
|
-$1.90 M
|
-$21.21 M
|
$2.81 M
|
-$1.38 M
|
-$24.32 M
|
-$15.91 M
|
-$4.99 M
|
| Income Before Tax Ratio |
-211.54
|
-119.87
|
-18.67
|
-0.05
|
-0.88
|
0.07
|
-0.03
|
-10.33
|
-14.09
|
-5.3
|
| Income Tax Expense |
$2.67 M
|
-$2.11 M
|
$83.00 K
|
$76.00 K
|
$72.00 K
|
$2.40 M
|
$0.00
|
$214.00 K
|
$0.00
|
$0.00
|
| Net Income |
-$71.42 M
|
-$57.83 M
|
-$45.89 M
|
-$2.01 M
|
-$21.30 M
|
$407.00 K
|
-$1.38 M
|
-$24.32 M
|
-$15.91 M
|
-$4.99 M
|
| Net Income Ratio |
-219.77
|
-115.66
|
-18.71
|
-0.05
|
-0.88
|
0.01
|
-0.03
|
-10.33
|
-14.09
|
-5.3
|
| EPS |
-1.59 |
-1.77 |
-2.17 |
-0.11 |
-1.18 |
0.0225 |
-0.0775 |
-1.5 |
-4.46 |
-1.2 |
| EPS Diluted |
-1.59 |
-1.77 |
-2.17 |
-0.11 |
-1.18 |
0.0221 |
-0.0775 |
-1.5 |
-4.46 |
-1.2 |
| Weighted Average Shares Out |
$45.03 M
|
$32.76 M
|
$21.10 M
|
$18.16 M
|
$18.11 M
|
$18.07 M
|
$17.81 M
|
$16.25 M
|
$3.57 M
|
$4.15 M
|
| Weighted Average Shares Out Diluted |
$45.03 M
|
$32.76 M
|
$21.10 M
|
$18.16 M
|
$18.11 M
|
$18.39 M
|
$17.81 M
|
$16.25 M
|
$3.57 M
|
$4.15 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
